Minnesota Dean Medical School on Pepsi Board
"When an expert joins this kind of board, clearly it's going to compromise their ability to speak out"
"When an expert joins this kind of board, clearly it's going to compromise their ability to speak out"
The FDA has just released its “Guidance on Drug Safety Information” abandoning its own proposed ‘DrugWatch Site Guideliens (2005), http://www.fda.gov/cder/guidance/6657dft.htm replacing it with an *asterisk and an impossible to find location on the Center for Drug Evaluation and Research (CDER) web page. A mere * is supposed to convey what…
The LAT reports that the Center for Evaluation of Risks to Human Reproduction has been outsourcing the writing of its "scientific" reports to an industry consulting firm, Sciences International.
Overshadowing all other health related news, a front page report in The Washington Post and the just released Breckenridge report evaluating FDA's abysmal performance on drug safety, http://ahrp.blogspot.com/2007/03/latest-report-blasts-fda-bungling-drug.html require Congressional action.
FDA administrators "mishandled the initiative through bureaucratic infighting, flawed planning and duplicative work performed by outside contractors." The report estimates that agency administrators wasted $25 million on a computer system that won't be functional before 2009.
This young child represents millions of children in the United States who are falling prey to licensed, but irresponsible prescribers of toxic drugs.
“Catastrophic side effects may be rare, but they become predictable when we treat so many children with so many drugs.”
The question is can these visits overcome industry's propaganda delivered under the guise of continuing medical education (CME) courses which physicians must take?
The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign." Its goal is to get one million people to stop and reevaluate the medications they are taking.
A commentary in the April 2007 issue of HARVAD magazine, AHRP board member, Stefan Kruszeuski, MD, urges his colleagues to abandon psychiatry’s diagnostic and therapeutic reductionism.
Drug safety is a public issue–and the FDA has been shown to be asleep at the helm as tens of thousands have died that could have lived had they and their physicians known the safety hazards of prescribed drugs.
The shift from Hippocratic medicine grounded in the “do no harm” principle, to corporate medicine has severed the unique physician-patient relationship based on a tacit understanding that the physician’s reasoned therapeutic recommendations will be governed the patient’s best interest.